.

. - .

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-003544-12-FR

Enrollment

648

Registered

2015-01-06

Start date

2017-10-06

Completion date

Unknown

Last updated

2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

. MedDRA version: 17.1 Level: PT Classification code 10074555 Term: Transplantation complication System Organ Class: 10022117 - Injury, poisoning and procedural complications

Interventions

Trade Name: SANDIMMUN Product Name: SANDIMMUN Pharmaceutical Form: Infusion INN or Proposed INN: CICLOSPORIN CAS Number: 59865-13-3 Concentration unit: mg/ml milligram(s)/millilitre Concentration type

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: . Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 432 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 216

Exclusion criteria

Exclusion criteria: .

Design outcomes

Primary

Measure	Time frame
Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Secondary

Measure	Time frame
Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Countries

France

Contacts

Public ContactDélégation de la Recherche Clinique

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr00330473751195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026

.